Cytokinetics
Peter Chu is an experienced professional in pharmaceutical engineering, currently serving as the Director of Pharmaceutical Engineering at Cytokinetics since February 2024. Prior roles include Director of Manufacturing and CMC at Alladapt Immunotherapeutics, Inc. from June 2022 to February 2024, and Associate Director of Process Engineering at Aimmune Therapeutics from March 2017 to June 2022. Earlier in the career, Peter held positions such as Senior Process Development Engineer at Novartis, Senior Process Engineer at Onyx Pharmaceuticals, and Staff Process Development Engineer at Alexza Pharmaceutical. Peter began the career as a Process Engineer at Johnson & Johnson. Educational background includes a Bachelor of Science in Chemical Engineering from the University of California, Berkeley, obtained between 1996 and 2000. Areas of expertise encompass process development and process qualification/validation.
This person is not in the org chart
This person is not in any offices
Cytokinetics
16 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.